IBA Worldwide
IBA develops, manufactures and supports medical devices and software solutions for cancer treatment by proton beam therapy.
Launch date
Employees
Market cap
AUD667m
Enterprise valuation
AUD666m (Public information from Sep 2024)
Share price
€13.7 IBAB.BR
Ottignies-Louvain-la-Neuve Walloon Brabant (HQ)
Authorizing premium user...